Stanhope v. Commissioner of Social Security Administration

CourtDistrict Court, D. Arizona
DecidedSeptember 6, 2019
Docket2:18-cv-04884
StatusUnknown

This text of Stanhope v. Commissioner of Social Security Administration (Stanhope v. Commissioner of Social Security Administration) is published on Counsel Stack Legal Research, covering District Court, D. Arizona primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Stanhope v. Commissioner of Social Security Administration, (D. Ariz. 2019).

Opinion

1 WO 2 3 4 5 6 IN THE UNITED STATES DISTRICT COURT 7 FOR THE DISTRICT OF ARIZONA

9 Stephanie Ann Stanhope, No. CV-18-4884-PHX-DMF

10 Plaintiff,

11 v. ORDER

12 Commissioner of Social Security Administration, 13 Defendant. 14 15 Plaintiff Stephanie Ann Stanhope (“Claimant”) appeals the Commissioner of Social 16 Security Administration’s decision to adopt the Administrative Law Judge’s (ALJ’s) ruling 17 denying her applications for Disability Insurance Benefits under Title II of the Social 18 Security Act and for Supplement Security Income under Title XVI of the Social Security 19 Act. (Doc. 1, Doc. 15-3 at 20)1 Claimant argues that ALJ Ted W. Armbruster erred by: 20 (1) assigning little weight to the opinions of John Porter, M.D., within a Physical Residual 21 Functional Capacity Questionnaire dated May 2018; and (2) improperly rejecting 22 Claimant’s testimony regarding her pain, symptoms, and level of limitation. (Doc. 18 at 23 4-16) 24 This Court has jurisdiction pursuant to 42 U.S.C. § 405(g) and with the parties’ 25 consent to Magistrate Judge jurisdiction pursuant to 28 U.S.C. § 636(c). For the reasons 26 set forth below, the Court will affirm the Commissioner’s decision.

27 1 Citation to the record indicates documents as displayed in the official Court electronic 28 document filing system maintained by the District of Arizona under Case No. CV-18- 04884-PHX-DMF. 1 I. BACKGROUND 2 A. Application and Social Security Administration review 3 Claimant was 51 when she filed her applications for disability insurance benefits 4 and supplemental security income on April 10, 2015, alleging a disability onset date of 5 March 3, 2014. (Doc. 15-6 at 2-3, 9; Doc. 15-3 at 17) The state agency initially determined 6 Claimant was not disabled in September 2015 (Doc. 15-4 at 2-12, 13-21), and again on 7 reconsideration in March 2016 (Id. at 24-34, 35-45). After conducting a hearing on 8 Claimant’s applications on May 3, 2018 (Doc. 15-3 at 83-143), the ALJ filed a notice of 9 an unfavorable decision on July19, 2018. (Id. at 14-29) Claimant then filed an appeal with 10 the Appeals Council, which was denied by notice dated October 22, 2018. (Id. at 2-5) At 11 that point, the Commissioner’s decision became final. Brewes v. Comm’r of Soc. Sec. 12 Admin., 682 F.3d 1157, 1162 (9th Cir. 2012). 13 B. Relevant medical treatment and imaging 14 1. Maricopa Integrated Health Systems 15 Claimant reported thoracic spine pain on May 31, 2014. (Doc. 15-8 at 5-14) X- 16 rays indicated an unremarkable thoracic spine. (Id.) Her blood oxygenation (“SpO2”) was 17 measured at 99%.2 (Id. at 7) On July 3, 2014, Claimant was seen for shortness of breath. 18 (Id. at 17-25) Her physical examination documented normal range of motion, a normal 19 psychiatric assessment, and SpO2 reading of 96%. (Id. at 20) In November 2014, Claimant 20 complained of musculoskeletal pain and it was noted she took Tylenol and Ultram for it. 21 (Id. at 27) Although she displayed diffuse mild wheezes and scattered rhonchi, her SpO2 22 was measured at 98%. (Id. at 28) 23 In February 2017, Claimant complained of chest congestion and cough with 24 shortness of breath. (Doc. 15-11 at 7) Her SpO2 reading was 95%. (Id. at 7) Claimant 25 exhibited normal range of motion and normal mood and affect. (Id. at 8) In March 2017, 26 it was reported that her cough had been treated with antibiotics with good results, but that 27

28 2 Claimant cites to a medical publication for the statement that a normal resting oxygen saturation of 95% or greater is considered normal. (Doc. 18 at 6) 1 her “illness came back.” (Id. at 12) Her SpO2 saturation level was 99%. (Id. at 14) She 2 was noted to complain of pain in her back radiating down her legs, but her review of 3 systems was negative for musculoskeletal issues. (Id.at 16-17) She exhibited a normal 4 range of motion and normal mood and affect. (Id. at 17) She was not in any respiratory 5 distress but had “wheezes.” (Id.) In April 2017, Claimant complained of memory loss and 6 decreased concentration. (Id. at 33) Her SpO2 level was measured at 99%. (Id.) She was 7 noted to have no pain, and demonstrated normal mood, affect, and behavior. (Id. at 33-34) 8 During a sleep study, Claimant tested negative for obstructive sleep apnea. (Id. at 45) 9 A pulmonary function test conducted in May 2017 identified a baseline SpO2 level 10 of 94%. (Id. at 54) Claimant denied leg edema. (Id. at 70) She demonstrated a normal 11 gait. (Id.at 72) Her musculoskeletal review was negative, with a normal range of motion. 12 (Id. at 80) She exhibited normal mood and affect. (Id.) On May 15, 2017, Claimant 13 complained of chronic back pain, but she displayed normal gait and station. (Id. at 84) In 14 July 2017, Claimant’s SpO2 was measured at 99%. (Doc. 15-9 at 10) She was encouraged 15 to perform aerobic exercise and walking. (Id. at 11) No lower extremity edema was 16 observed, and Claimant’s mood and affect were normal. (Id. at 15) On July 18, 2017, 17 while being evaluated for bradycardia, Claimant reported no shortness of breath, no 18 swelling in her hands or feet, and no dizziness, headaches, fatigue or pain. (Id. at 28) She 19 reported memory issues such as forgetting where she placed her keys or wallet. (Id. at 29) 20 She had a normal gait. (Id. at 30) On July 21, 2017, Claimant’s physical examination 21 indicated a SpO2 level of 96% and she reported hip pain. (Id. at 34) She exhibited a 22 normal range of motion but displayed an anxious mood. (Id.) She was implanted with a 23 pacemaker on September 13, 2017, to address symptoms of bradycardia. (Id. at 45) Two 24 weeks post-implant, Claimant reported she felt better, slept better, had less anxiety, and 25 thought her memory was improving. (Id. at 79) 26 In October 2017, Claimant exhibited normal range of motion, normal behavior, 27 mood, affect, thought content and judgment. (Id. at 89) In November 2017, her SpO2 28 measured 100% and she was reported to be in no pain. (Id. at 95) In February 2018, 1 Claimant was seen at urgent care for a headache lasting one week. (Id. at 99) Her treatment 2 notes included her reports of back pain radiating to her flanks and abdomen that worsened 3 with walking. (Id. at 99) The review of symptoms indicated decreased range of motion 4 and tenderness in her neck. (Id. at 101) Later in February 2018, Claimant complained 5 about feeling overwhelmed, her desire to not leave home, and forgetfulness. (Id. at 106) 6 She was seen in March 2018 for her complaint of memory changes. (Id. at 113-114) Her 7 assessment indicated: normal attention span, concentration, and fund of knowledge; good 8 immediate memory and recall of 2 out of 3 items after 5 minutes; a mini-mental 9 examination score of 24/30, including loss of 4 points for counting numbers backwards; 10 normal muscle tone; 5 of 5 muscle strength throughout; and normal gait and stance. (Id.) 11 The doctor noted memory changes that he attributed to depression and anxiety. (Id. at 114) 12 Claimant also reported pain in her back and neck at a level of 3 out of 10 and said she was 13 using ibuprofen and baths to relieve her pain. (Id. at 115) 14 On March 21, 2018, Claimant presented complaining of chest pain and shortness of 15 breath on exertion and when lying on her back, but without edema, fainting or heart 16 palpitations. (Id. at 119) Her SpO2 level was 98%. (Id.) She was nervous and anxious. 17 (Id.) On March 27, 2018, Claimant’s SpO2 was 99%. (Doc. 15-11 at 122) She displayed 18 a normal range of motion in her musculoskeletal system and normal mood and affect.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Richardson v. Perales
402 U.S. 389 (Supreme Court, 1971)
Molina v. Astrue
674 F.3d 1104 (Ninth Circuit, 2012)
Orn v. Astrue
495 F.3d 625 (Ninth Circuit, 2007)
Lingenfelter v. Astrue
504 F.3d 1028 (Ninth Circuit, 2007)
Kim Brown-Hunter v. Carolyn W. Colvin
806 F.3d 487 (Ninth Circuit, 2015)
Converse Cooperage & Yocono Co. v. Reinecke
26 F.2d 747 (N.D. Illinois, 1928)
Lester v. Chater
81 F.3d 821 (Ninth Circuit, 1995)
Reddick v. Chater
157 F.3d 715 (Ninth Circuit, 1998)

Cite This Page — Counsel Stack

Bluebook (online)
Stanhope v. Commissioner of Social Security Administration, Counsel Stack Legal Research, https://law.counselstack.com/opinion/stanhope-v-commissioner-of-social-security-administration-azd-2019.